| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/18/2010 | WO2009112837A3 A topical ectoparasiticide composition |
| 02/18/2010 | WO2009112769A3 Pharmaceutical dye extracted from cranberry with high proanthocyanidin a concentration |
| 02/18/2010 | WO2009092073A3 Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
| 02/18/2010 | WO2009077769A3 Carrier |
| 02/18/2010 | WO2009046281A3 Injectable particles |
| 02/18/2010 | WO2009027506A3 Local topical administration formulations containing fipronil |
| 02/18/2010 | US20100041867 Reversible pegylated drugs |
| 02/18/2010 | US20100041827 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly |
| 02/18/2010 | US20100041826 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly |
| 02/18/2010 | US20100041773 Disruptors of early/recycling endosomes |
| 02/18/2010 | US20100041771 Bioreponsive Polymers |
| 02/18/2010 | US20100041744 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof |
| 02/18/2010 | US20100041739 Transfection Reagent |
| 02/18/2010 | US20100041688 Revaprazan-containing solid dispersion and process for the preparation thereof |
| 02/18/2010 | US20100041627 Compositions comprising polymeric emulsifiers and methods of using same |
| 02/18/2010 | US20100041624 Buprenorphine formulations for intranasal delivery |
| 02/18/2010 | US20100041292 Active polymer compositions |
| 02/18/2010 | US20100040690 Adhesive mixture for transdermal delivery of highly plasticizing drugs |
| 02/18/2010 | US20100040682 Fenofibrate tablets |
| 02/18/2010 | US20100040678 Organic compounds |
| 02/18/2010 | US20100040662 Fixation Devices For Tissue Repair |
| 02/18/2010 | US20100040645 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete domain and is cd4+ t cell-independent |
| 02/18/2010 | US20100040580 Freeze-dried composition of inactivated virus envelope with membrane fusion activity |
| 02/18/2010 | US20100040570 Silicone modified fatty acids, method of preparation and usage thereof |
| 02/18/2010 | US20100040566 Emulsion |
| 02/18/2010 | US20100040553 Spherical ferrite nanoparticle and method for production thereof |
| 02/18/2010 | US20100040542 Chelator conjugates |
| 02/18/2010 | CA2733963A1 Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsions |
| 02/18/2010 | CA2733908A1 Pharmaceutical composition and administrations thereof |
| 02/18/2010 | CA2733778A1 Stabilized pharmaceutical composition |
| 02/18/2010 | CA2733724A1 Mucoadherents compositions and their use |
| 02/18/2010 | CA2733686A1 Aabb-poly(depsipeptide) biodegradable polymers and methods of use |
| 02/18/2010 | CA2732508A1 Multi-arm polymeric alkanoate conjugates |
| 02/18/2010 | CA2731473A1 Carrier system for biological agents containing organosilicon compounds and uses thereof |
| 02/18/2010 | CA2731353A1 Stable injectable oil-in-water docetaxel nanoemulsion |
| 02/18/2010 | CA2731316A1 Pharmaceutical compositions |
| 02/17/2010 | EP2154160A1 Hydroxyalkyl starch derivatives |
| 02/17/2010 | EP2153850A1 Liquid compositions comprising dextran, in situ formed implants obtained thereof |
| 02/17/2010 | EP2153843A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/17/2010 | EP2153838A1 Anti-norovirus agent, and composition comprising the same |
| 02/17/2010 | EP2153836A1 Film-forming liquid formulations for drug release to hair and scalp |
| 02/17/2010 | EP2153828A2 Composition for the Transdermal Delivery of Fentanyl |
| 02/17/2010 | EP2153827A2 Composition for the Transdermal Delivery of Fentanyl |
| 02/17/2010 | EP2153826A2 Nanoparticles comprising a cyclodextrin and a biologically active molecule and uses thereof |
| 02/17/2010 | EP2153820A1 Liposome and method for producing liposome |
| 02/17/2010 | EP2153819A2 Compositions containing therapeutically active components having enhanced solubility |
| 02/17/2010 | EP2152782A1 Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof |
| 02/17/2010 | EP2152757A1 Functionalization of nanoparticles by glucosamine derivatives |
| 02/17/2010 | EP2152754A2 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 02/17/2010 | EP2152751A1 Fusion or linked proteins with extended half life |
| 02/17/2010 | EP2152315A2 Sustained delivery formulations of risperidone compounds |
| 02/17/2010 | EP2152313A1 Oral nicotine formulation buffered with amino acid |
| 02/17/2010 | EP2152312A1 Low-viscous anthracycline formulation |
| 02/17/2010 | EP2152251A2 Increased drug loading capacity of polymeric material |
| 02/17/2010 | EP2152241A1 Method of delivering a protein into a cell |
| 02/17/2010 | EP2152239A1 Stable oxaliplatin composition for parenteral administration |
| 02/17/2010 | EP2152237A1 Novel pharmaceutical composition |
| 02/17/2010 | EP2152233A1 High concentration factor vii polypeptide formulations comprising an aromatic preservative and an antioxidant |
| 02/17/2010 | EP2152078A1 Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use |
| 02/17/2010 | EP1750668B1 Liquids containing suspended glass particles |
| 02/17/2010 | EP1594459B1 Drug delivery from rapid gelling polymer composition |
| 02/17/2010 | EP1492410B1 Triglyceride fat |
| 02/17/2010 | EP1304384B1 Biodegradable articles obtained from enzymatically synthesized amylose |
| 02/17/2010 | CN201404486Y Controlled-release micro sphere of chitosan coating 3,5-dyhydroxy-4-isopropyl toluylene |
| 02/17/2010 | CN101648028A vitamin-targeted imaging agents |
| 02/17/2010 | CN101648023A DNA and nano lamellar hydroxylapatite compound as well as preparation method and application thereof |
| 02/17/2010 | CN101648022A Nanometer microsphere or hollow sphere of casein or casein-polyacrylic acid compound and preparation method and application thereof |
| 02/17/2010 | CN101648021A Application of methylene blue used as cancer-philic targeting substance and nano medicine containing methylene blue |
| 02/17/2010 | CN101648020A Application of oleic acid used as cancer-philic targeting substance and anticancer targeting medicine |
| 02/17/2010 | CN100590131C Methods and compounds for the targeting of protein to exosomes |
| 02/17/2010 | CN100589844C Mono-modified polyethyleneglycol-insulin complexes and preparation method thereof |
| 02/17/2010 | CN100589843C Stable polymer micelle medicine carrging system |
| 02/17/2010 | CN100589809C Quaternised ammonium cyclodextrin compounds |
| 02/16/2010 | USRE41134 Slow release vehicles for minimizing skin irritancy of topical compositions |
| 02/16/2010 | US7662933 Pegylated granulocyte colony stimulating factor (G-CSF) to treat a hematopoietic disorder related to reduced neutrophil count, such as infectious disease, sepsis, or a result of radiotherapy or chemotherapy |
| 02/16/2010 | US7662864 Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent |
| 02/16/2010 | US7662855 For treatment of skin disorders (acne); solubilized in alcohol |
| 02/16/2010 | US7662800 Hyaluronic acid derivatives |
| 02/16/2010 | US7662788 Abuse-resistant amphetamine prodrugs |
| 02/16/2010 | US7662787 lisdexamfetamine, lisdexamfetamine dimesylate and lisdexamfetamine hydrochloride; attention deficit hyperactivity disorder (ADHD), ADD, narcolepsy, and obesity |
| 02/16/2010 | US7662773 Natriuretic compounds, conjugates, and uses thereof |
| 02/16/2010 | US7662771 Drug delivery; controlled/sustained release |
| 02/16/2010 | US7662767 inhibiting complexation of intercalating molecules with polynucleotides; using modified xanthine molecules as a binding agent; drug delivery system for compounds that have low solubility in aqueous media, including anti-neoplastic agents |
| 02/16/2010 | US7662629 Cationic peptide scaffold conjugated to a nuclear targeting peptide through a specified hydrolysis resistant chemical linkage; use in transfection i.e. nonviral gene transfer |
| 02/16/2010 | US7662413 Extracts of sacred water lotus for the treatment of cancer |
| 02/16/2010 | US7662409 Biocompatible protein materials compressed with one or more biocompatible solvents to remove bulk solvent and form an interacting protein matrix material. |
| 02/16/2010 | US7662408 Sustained-release preparations |
| 02/16/2010 | US7662403 Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof |
| 02/16/2010 | US7662393 comprises alkali metal salt, alkaline earth metal salt, and citrate/phosphate buffer; improved stability |
| 02/16/2010 | US7662387 administering a conjugate of antibody ( humanized, chimeric or constant region) and a drug such as fetoprotein/alpha-/, monomethyl auristatin E or monomethyl auristatin F to treat CD70-expressing cancer selected from a kidney tumor, a B cell lymphoma, a thymic carcinoma, and a nasopharyngeal carcinoma |
| 02/16/2010 | US7662383 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction; polymerase chain reaction |
| 02/16/2010 | US7662374 Dual-specificity antibody having specificity for both an activated erbB2 receptor and erbB1 dimers, without significant affinity for monomeric EGFr that is not activate; specificity of the antibodies is due to their recognition and binding of activation epitopes; diagnosis, imaging and for treating tumor |
| 02/16/2010 | US7662371 Composition for lowering the concentration of intestinal pathogenic peptides |
| 02/16/2010 | US7662369 Stabilized interferon compositions |
| 02/16/2010 | US7662365 Polymer conjugates of opioid antagonists |
| 02/16/2010 | US7662360 boron neutron capture therapy |
| 02/16/2010 | CA2462482C Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient |
| 02/16/2010 | CA2427938C Novel temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution, composition and preparation thereof |
| 02/16/2010 | CA2426682C Intraoral rapid-disintegrating medicinal compositions and production process thereof |
| 02/16/2010 | CA2422267C Drying method for selectively removing volatile components from wet coatings |